Pembrolizumab for adjuvant treatment of locally advanced cutaneous squamous cell carcinoma after surgery and radiotherapy ID 6473

  • In development
  • GID-TA11582
  • Expected publication date: TBC

Register as a stakeholder

Documents

Documents created during the development process.

Referral

Topic selection